HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glucagon-like peptide-1 (9-36)-amide

antagonizes antral motility inhibition by GLP-1 (7-36)amide

Also Known As:

GLP-1 (9-36)-NH2; GLP-1 (9-36)amide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gastrointestinal Hormones: 573
    - Proglucagon: 128
      - Glucagon-Like Peptides: 424
        Glucagon-Like Peptide 1: 6089
        glucagon-like peptide-1 (9-36)-amide: 1

Experts

1.	Andersen, Ulrik B: 1 article (10/2019)
2.	Bremholm, Lasse: 1 article (10/2019)
3.	Hartmann, Bolette: 1 article (10/2019)
4.	Holst, Jens Juul: 1 article (10/2019)
5.	Hornum, Mads: 1 article (10/2019)
6.	Marstrand, Simone: 1 article (10/2019)
7.	Nissen, Anne: 1 article (10/2019)
8.	Rosenkilde, Mette Marie: 1 article (10/2019)
9.	Skov-Jeppesen, Kirsa: 1 article (10/2019)

Related Diseases

1.	Bone Resorption 10/01/2019 - "In conclusion, we show that GLP-1 receptor agonists, but not the primary metabolite GLP-1 (9-36)amide, decrease bone resorption, and suggest that GLP-1 may be part of the gut-bone axis. "

Related Drugs and Biologics

1.	Glucagon-Like Peptide 1 (GLP 1)
2.	Glucagon-Like Peptide-1 Receptor Agonists